Although bioinformatics analysis has revealed a correlation between SLC1A5 expression and the prognosis of glioma patients [36], the precise role of SLC1A5 and its relationship with the immune status of glioma patients and immunotherapy remain unclear. This evidence concerns the gene SLC1A5 and glioma.